🟢 Icecure Medical is trading 8% up in pre-market ahead of August 12 first-half 2026 results

Icecure Medical is trading at $3.79, up 7.98% ahead of its first-half 2026 financial and operating results, scheduled for release before the Nasdaq open on August 12, 2026.

• Management will discuss the results and corporate developments during a 10:00 a.m. EDT conference call.
• The move follows consecutive gains on August 10 and August 11, while broader pre-market indexes are also higher.